发明名称 FUSION PROTEIN
摘要 The present invention provides a new fusion protein which can specifically suppress the autoantibodies, which can effectively prevent or treat the autoimmune disease of autoantibody type, and which can be expressed in an amount sufficient for industrial production. A fusion protein, characterized in that, a protein (X) containing a site recognized by autoantibodies which are a cause of the autoimmune disease of autoantibody type is connected to a protein (A) containing a fragment of the antibody heavy chain constant region which exhibits the antibody-dependent cellular cytotoxicity with a linker peptide (L) consisting of one or more amino acid (s), wherein the protein (X), the linker peptide (L) and the protein (A) are connected in this order by means of peptide bond from N terminal to C terminal.
申请公布号 EP2698386(A4) 申请公布日期 2014.12.03
申请号 EP20120770896 申请日期 2012.04.02
申请人 NIHON PHARMACEUTICAL CO., LTD. 发明人 KOGURE, TAKAHISA;NAKAJIMA, KENJI;HOMMA, MASAYUKI
分类号 C07K19/00;A61K38/00;A61P37/06;C07K14/47;C07K14/705;C07K16/18;C12N15/09;C12P21/02 主分类号 C07K19/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利